From Medison Co.,Ltd.;
'The SONOACE 9900 offers exceptional B/W image clarity by newly developed FINE™ Filter technology, which contributes to edge enhancement and average filtering in real-time. OSIO™(Organ Specified Image Optimization)sets the best diagnosis environment with minimum manual operation and increases patient throughput. Also, color images are improved with better color Doppler performance, high color sensitivity, fine pixel image, and reduced flash artifact across all probes.'

'The SONOACE 9900 PRIME from Medison offers full range of applications specially designed for your practice. With the addition of the new C-Square Processing and PSAD Beamformer, SONOACE 9900 PRIME provides higher contrast resolution and clearer image quality in all application ranges. Based on super clear image resolution and versatile 3D functions, SONOACE 9900 PRIME offers you the true value of future ultrasound technology.'

Ultrasound contrast agents (USCAs) improve the sensitivity of various ultrasound applications. They usually stay within the vascular space and can be injected several times. Nevertheless the contrast enhancement is limited caused by physiologic clearance and bubble destruction.

Different injection techniques to improve the imaging:
Continuous infusion yield a steady-state concentration of the USCAs, greater examination time with optimal enhancement, avoid bloom and possibly other artifacts. Continuous infusion also allows the sonographer to optimize the effective dose individually during the examination.

See also Power Modulation.